United States · Wires & real time · PR Newswire

Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results

Published by PR Newswire · United States 51 min ago

Ifetroban was well tolerated in patients with systemic sclerosis NASHVILLE, Tenn., Oct. 23, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), an…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Associated Press (Business)

Brazil’s Lula opens state toolbox to woo voters in runoff against Bolsonaro. Here’s what is on offer

Dow Jones Newswires

Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results

Share

Also worth reading

Brazil’s Lula opens state toolbox to woo voters in runoff against Bolsonaro. Here’s what is on offer

Advancing Government Intelligence: Insights From the Data and Intelligence Training Forum